Ocular Diseases and Behçet’s Syndrome
Moving in Gut, bioRxiv, medRxiv, Nature Communications and New England Journal of Medicine.
- Moved, week to 23 Oct 2026
- 0
- Papers in 60 days
- 6
Rebuilt
Moved this week
Nothing in this topic has moved yet this week.
Latest in Ocular Diseases and Behçet’s Syndrome
Newest first · last 60 days
Roginolisib demonstrates safety and achieves over 90% continuous PI3Kδ inhibition in patients with advanced cancers, including metastatic uveal melanoma, with median OS of 20.8 months.
- Open access
Persistent elevation of faecal calprotectin >70 µg/g in asymptomatic first-degree relatives predicts presymptomatic Crohn's disease with 89% sensitivity and 94% specificity.
- 6 cites
Molecular features detectable years before clinical IBD diagnosis suggest a preclinical phase with potential for early intervention.
- Open access
Add Ocular Diseases and Behçet’s Syndrome as an interest in JClub
Browse JClub
Journals this month
- bioRxiv6192
- medRxiv1716
- PNAS472
- Sci Adv398
- JAMA274
- Environ Res230
- BMJ200
- Nat Commun171
- Environ Pollution165
- Nature161
- NEJM146
- Science141
- Lancet132
- Cell Rep130
- Curr Biol108
- J Exp Bot108
- mBio107
- Plant Cell Environ107
Topics moving, week to 23 Oct 2026
- Single-cell and spatial transcriptomics6
- Neuroinflammation and Neurodegeneration Mechanisms5
- Bacteriophages and microbial interactions5
- Gut microbiota and health5
- Genomics and Phylogenetic Studies4
- Cancer Genomics and Diagnostics4
- Cancer Immunotherapy and Biomarkers4
- Alzheimer's disease research and treatments3
- Inflammatory Bowel Disease3
- Influenza Virus Research Studies3